Brendan Smith
Stock Analyst at TD Cowen
(1.78)
# 3,708
Out of 5,182 analysts
18
Total ratings
36.36%
Success rate
4.89%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PASG Passage Bio | Downgrades: Hold | n/a | $5.84 | - | 1 | Apr 21, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $19 → $16 | $14.57 | +9.81% | 3 | Apr 10, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $7.87 | +52.48% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $60.94 | -29.44% | 1 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $11.79 | +103.56% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $4.40 | +13.64% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $25.91 | +50.52% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $65.36 | +37.70% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $8.22 | -14.84% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $306.16 | +14.32% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $73.91 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $19.87 | - | 1 | Dec 5, 2022 |
Passage Bio
Apr 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.84
Upside: -
Simulations Plus
Apr 10, 2026
Maintains: Hold
Price Target: $19 → $16
Current: $14.57
Upside: +9.81%
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $7.87
Upside: +52.48%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $60.94
Upside: -29.44%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $11.79
Upside: +103.56%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $4.40
Upside: +13.64%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $25.91
Upside: +50.52%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $65.36
Upside: +37.70%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $8.22
Upside: -14.84%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $306.16
Upside: +14.32%
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $73.91
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $19.87
Upside: -